How to Treat the Obese? The Importance of Body Mass Index in the Emergency and Critical Care Setting: A Structured Narrative Review
Bratislava Medical Journal, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s44411-026-00922-6
- Dergi Adı: Bratislava Medical Journal
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Ultimate (EBSCO)
- Anahtar Kelimeler: Body mass index, Critical care, Drug dosing, Emergency medicine, GRADE, Mechanical ventilation, Obesity, Venous thromboembolism prophylaxis
- Çanakkale Onsekiz Mart Üniversitesi Adresli: Evet
Özet
Background: Obesity is now the most prevalent form of malnutrition in most health systems, and patients living with obesity constitute a large and growing proportion of emergency department (ED) and intensive care unit (ICU) admissions. Body mass index (BMI) remains the operational descriptor used to triage, dose, ventilate and prognosticate these patients, yet its validity as a bedside instrument in acute illness has never been formally appraised across the breadth of acute care. Objectives: To identify, appraise and synthesise the highest-level evidence on how BMI and adiposity influence the assessment and treatment of adults in emergency and critical care, and to grade the certainty of that evidence across the domains of airway management, mechanical ventilation, resuscitation, pharmacotherapy, thromboprophylaxis, nutrition, diagnostics and logistics. Methods: A structured narrative review was conducted, based on a structured search of MEDLINE via PubMed supplemented by targeted domain searches and reference-list checking. MEDLINE/PubMed was searched from inception to 1 October 2026 for systematic reviews, meta-analyses, randomised controlled trials, clinical practice guidelines and consensus statements addressing adults with a BMI of 30 kg/m2 or above managed in emergency, perioperative-critical or intensive care settings. Methodological quality was assessed with AMSTAR 2, RoB 2 and ROBINS-I, and the certainty of evidence for each clinical domain was rated using the GRADE approach. Because included designs and outcomes were heterogeneous, findings were synthesised narratively by clinical domain. Results: Fifty-nine records informed the synthesis. Certainty of evidence was moderate for tidal-volume scaling to predicted body weight, for the increased risk of severe peri-intubation hypoxaemia, and for prophylactic non-invasive ventilation after extubation; it was low to very low for the so-called obesity paradox, for chest-compression depth targets, for extracorporeal membrane oxygenation candidacy and for most weight-based dosing recommendations. Standard fixed-dose thromboprophylaxis may deliver sub-prophylactic exposure as BMI rises, with no consistent difference in major bleeding between the agents in routine use. Across every domain, patients with class III obesity were either excluded from, or markedly under-represented in, the pivotal trials that generate current recommendations. Conclusions: BMI remains indispensable as a rapid trigger for anticipatory planning in acute care, but it is an unreliable dosing and prognostic variable when used alone. The defensible position is a two-step approach: use BMI to activate an obesity-specific care bundle, then substitute physiologically appropriate descriptors, height-based for lung size, lean-mass-based for hydrophilic drugs and total-body-weight-based for lipophilic drugs, for each individual decision. The most urgent research priority is the deliberate inclusion of patients with class III obesity in acute care trials.